Short progression-free survival of ALK inhibitors sensitive to secondary mutations in ALK-positive NSCLC patients

Naoki Haratake, Takashi Seto, Shinkichi Takamori, Ryo Toyozawa, Kaname Nosaki, Naoko Miura, Taro Ohba, Gouji Toyokawa, Kenichi Taguchi, Masafumi Yamaguchi, Mototsugu Shimokawa, Mitsuhiro Takenoyama

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Short progression-free survival of ALK inhibitors sensitive to secondary mutations in ALK-positive NSCLC patients'. Together they form a unique fingerprint.

Medicine & Life Sciences